4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-021000
Chief Operating Officer bought 32,508 shares at an average $0.79 ($25,574)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2024-06-18 | Purchase | +12,000 | $0.86 | $10,320 | 165,624 | D: show line 1 in the form |
| Cittadine Andrew Chief Operating Officer | 2024-06-20 | Purchase | +20,508 | $0.74 | $15,254 | 186,132 | D: show line 2 in the form |
| Open-market purchases · 32,508 sh · avg $0.79 · $25,574 | |||||||
Loading xslF345X05/rdgdoc.xml…